Alliancebernstein L.P. lowered its holdings in Stericycle Inc (NASDAQ:SRCL) by 1.8% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 131,907 shares of the business services provider’s stock after selling 2,388 shares during the quarter. Alliancebernstein L.P. owned 0.15% of Stericycle worth $7,740,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Standard Life Aberdeen plc grew its holdings in Stericycle by 34.1% in the 2nd quarter. Standard Life Aberdeen plc now owns 20,151 shares of the business services provider’s stock valued at $1,316,000 after buying an additional 5,119 shares during the last quarter. Cornerstone Wealth Management LLC acquired a new stake in Stericycle in the 2nd quarter valued at approximately $222,000. Schaper Benz & Wise Investment Counsel Inc. WI grew its holdings in Stericycle by 0.8% in the 3rd quarter. Schaper Benz & Wise Investment Counsel Inc. WI now owns 134,396 shares of the business services provider’s stock valued at $7,886,000 after buying an additional 1,065 shares during the last quarter. Patton Albertson Miller Group LLC grew its holdings in Stericycle by 26.5% in the 2nd quarter. Patton Albertson Miller Group LLC now owns 9,211 shares of the business services provider’s stock valued at $601,000 after buying an additional 1,930 shares during the last quarter. Finally, MAI Capital Management acquired a new stake in Stericycle in the 2nd quarter valued at approximately $245,000. 96.58% of the stock is currently owned by hedge funds and other institutional investors.
Shares of SRCL stock opened at $43.93 on Monday. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.93. Stericycle Inc has a 12 month low of $43.40 and a 12 month high of $76.73. The company has a market capitalization of $3.98 billion, a price-to-earnings ratio of 10.12, a PEG ratio of 1.14 and a beta of 0.51.
A number of analysts have issued reports on the company. Zacks Investment Research raised Stericycle from a “sell” rating to a “hold” rating in a report on Monday, September 17th. BidaskClub downgraded Stericycle from a “buy” rating to a “hold” rating in a research report on Saturday, September 22nd. Barrington Research set a $72.00 price objective on Stericycle and gave the stock a “buy” rating in a research report on Friday, October 5th. Northcoast Research reiterated a “neutral” rating on shares of Stericycle in a research report on Friday, October 12th. Finally, Bank of America started coverage on Stericycle in a research report on Monday, October 22nd. They issued an “underperform” rating and a $53.00 price objective for the company. Five research analysts have rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $64.38.
Stericycle Company Profile
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.
Featured Article: Net Asset Value (NAV)
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.